Sign up
Healthed-White-on-Blue
Woodward, Michael

A/Prof Michael Woodward AM

Geriatrician; Director, Dementia Research, Austin Health
A/Prof Michael Woodward AM is a Senior Geriatrician with a passion for health promotion in older people, including vaccine-preventable diseases. He is Director of Aged Care Research at Austin Health and has conducted several trials of vaccines. He is a member of the Scientific Advisory Committee of the Immunization Coalition and has written the Position Paper on Immunization of older people for the Australian and New Zealand Society of Geriatric Medicine. In 2016 he received Membership of the Order of Australia for his work in geriatric medicine and his communication to professionals.

More from this expert

003-Woodward-Litt-Feature
Monographs iconMonographs

Closing the Immunisation Gap in Older Australians

This article discusses how GPs can improve the vaccination coverage among older Australians which is currently poor despite the ready availability, safety and effectiveness of these vaccines. Written by A/Prof Michael Woodward AM, MB, BS, MD, FRACP, and A/Prof John Litt MB, BS, DRACOG, MSc(Epid), FRACP, FAFPHM, PhD

Medical,Personnel,Filling,A,Syringe,Needle,With,Rsv,Vaccine,From

RSV Vaccine is on the NIP – What You Need to Know

Associate Professor Michael Woodward AM provides an update on this new initiative including who will now be eligible for this free vaccine.

By A/Prof Michael Woodward AM
Podcasts iconPodcasts
Image_Michael Woodward_C3.5_SWCH260

RSV prevention in adults: NIP listing for older adult RSV vaccine

In this Product Explainer, A/Prof Michael Woodward AM, Geriatrician, outlines NIP eligibility criteria and provides practical guidance on recombinant, adjuvanted RSV vaccination, administration and co-administration in older adults.

By A/Prof Michael Woodward AM
Videos iconVideos
Pneumococcal,Vaccine,In,A,Vial,,Immunization,And,Treatment,Of,Infection,

The new pneumococcal vaccination for older adults – What you need to know

A/Prof Michael Woodward explains the reasons for this new vaccine, and suggests ways on how and why health professionals can and should help to promote its uptake.

By A/Prof Michael Woodward AM
Podcasts iconPodcasts
Woodward, Michael_capvax

Introducing: Pneumococcal 21-valent conjugate vaccine

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM introduces a 21-valent pneumococcal conjugate vaccine and discusses implementation considerations for GPs and healthcare immunisers (5 mins).

By A/Prof Michael Woodward AM
Videos iconVideos

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast